SCHEMBL2831900

SCHEMBL2831900

CON=C(C)c1ccc(-c2ccc(C(F)(F)F)cc2)c(-c2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.43
KIF11 P52732 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CTSA P10619 1/20 0.38
DPP4 P27487 1/20 0.37
MAPK13 O15264 1/20 0.37
RAF1 P04049 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
TOP1 P11387 2/20 0.37
DHODH Q02127 2/20 0.36
MAPT P10636 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKT1 P31749 1/20 0.35
AKT2 P31751 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13287427 1.00 BACE1 (0.43) BACE1KIF11MEN1KMT2ACTSA
SCHEMBL13287383 0.89 MAPT (0.41) MEN1KMT2AMAPTADORA2AADORA1
SCHEMBL13287341 0.85 DHODH (0.39) BACE1KIF11MEN1KMT2ACTSA
SCHEMBL2833946 0.81 BACE1 (0.51) BACE1KIF11MEN1KMT2ACTSA
SCHEMBL2837655 0.81 BACE1 (0.48) BACE1KIF11CTSADHODHMAPT
SCHEMBL2832416 0.81 BACE1 (0.48) BACE1KIF11CTSADHODHMAPT
SCHEMBL2834553 0.76 BACE1 (0.45) BACE1KIF11CTSADPP4MAPK13
SCHEMBL2833627 0.76 BACE1 (0.45) BACE1KIF11CTSADPP4MAPK13
SCHEMBL2830992 0.75 DHODH (0.54) BACE1MEN1KMT2ADHODHMAPT
SCHEMBL2831678 0.75 DHODH (0.54) BACE1MEN1KMT2ADHODHMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728014-B2 Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity ALLERGAN, INC. 2010-06-01 US disclosed
US-20080064872-A1 HETEROAROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR AGONIST BIOLOGICAL ACTIVITY ALLERGAN, INC. 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064872-A1 HETEROAROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR AGONIST BIOLOGICAL ACTIVITY S1PR4, S1PR3, S1PR1 BACE1 551/4885KIF11 4500/4885MEN1 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.